High plasma levels of phenobarbital are known to produce profound effects on the EEG background activity. Phenobarbital therapy frequently is administered to the neonate with seizures prior to the first EEG recording. Therefore, it is questionable whether in these neonates alterations of the EEG background activity are related to anticonvulsive therapy.
Introduction
The prognostic value of the EEG in premature and term neonates is weIl established . Specifically, it has been shown that in neonatal seizures the background activity of the EEG is of far greater prognostic significance than the paroxysmal abnormalities (Watanabe 1978) . However, barbiturates are known to produce profound efTects on the EEG background activity. Since anticonvulsive therapy frequently is administered to the neonate with seizures prior to the first EEG recording, the prognostic value ofthe EEG seems questionable. To evaluate this apparent dilemma, the present study was undertaken to determine whether the changes noted in the EEGs of neonates under treatment with phenobarbital are related to either the underlying brain pathology or are secondary to barbiturate therapy. Special attention was paid to the outcome of the neonates.
Materials and methods
The clinical data and EEGs of26 newborn infants who had seizures were analyzed. Fifteen ofthe infants were delivered at term while eleven were premature. All were clinically ill and were'treated in the Infant Special Care Center of the U niversity Hospital. The etiologies of the seizures were ascertained from the diagnostic workups in the clinical record. Anticonvulsant therapy with phenobarbital was evaluated and related to the EEG information. The phenobarbital dosage schedules employed and plasma barbiturate levels (mg/dl) were gathered from information in the clinical record.
The EEGs consisted of 16 channel recordings with an electrode montage adapted for the newborn infant from the International 10-20 system, according to the technique reported by Werner et al 1977. Nine tin electrodes with a diameter of 6 mm were attached with collodian at Fp4, F ps , T 4, T], C 4 , Cz, C 3 , O 2 , 0 1 • Electrode-skin impedance was below 5 kohms. In most cases, ECG, respiration, EMG and EOGs were recorded. The Grass Model 8 amplifier high frequency filters were set at 70 Hz and the time constant at 0.12 seconds.
The EEG background activity was interpreted according to the following four classifications: (Watanabe 1978) . In premature infants with discontinuous traeing the interburst periods seem to be prolonged for conceptional age but physiologie patterns for conceptional age are still present.
In addition to these four patterns, an electrical seizure discharge was defined as repetitive unifocal or multifocal spikes and sharp waves occurring during electrical bursts or du ring the low voltage phase of the discontinuous (or altemating) tracings of the neonate. This activity occurs with an abrupt onset and in sharp contrast to the ongoing background activity. Since the duration of individual spikes in neonates can be much longer than the time span of individual spikes in older children and adults (Laget and Salbreux 1967) , the differentiation of spikes from sharp waves is not applicable (Engel 1975) .
Phenobarbital levels were determined using the Quantitative Enzyme Immunoassay Method (Emit~aed, SYVA, Palo Alto, CA; Rubenstein et al 1972). Levels are reported in mg/dl which corresponds to 1/10 Jlg/ ml.
Results
The clinical diagnosis EEG and phenobarbital levels noted in this group of26 infants are summarized in Table I .
Sinee this is a retrospective study, the phenobarbital levels varied from case to case in regards to the onset, duration and intervals of therapy. Phenobarbital was administered as a loading dose of 10 mg/kg in 18 infants and 14 mg/kg in four. Maintenance doses of 2.5 mg/kg were given at intervals of 12 hours. In 13 of the 18 infants, additional phenobarbital doses were administered to control clinical seizures or raise the blood concentration to therapeutic levels. Further variations in the initiation of therapy were noted in infant No. 2 who reeeived only 5 mg/kg. In no instance was there a marked change in the phenobarbital dose between the recording ofthe EEG and the measurement of plasma level. Phenytoin was added to eontrol seizures in eight cases.
In 16 cases the phenobarbital concentrations were measured on the day of the EEG reeording, while six were measured one day before and after the EEG. Two were measured up to two days after the EEG. Treatment was established in 16 infants more than two days prior to the EEG reeording.
Phenobarbital plasma eoncentrations varied with the different therapeutic regimes employed. Figures 1--4 demonstrate these variations in four infants.
Electroencephalograms were obtained on the 26 infants between one and 26 days after birth, with 46 percent performed in the first week (Tables land 11) . Inactive tracings were seen in two infants (Nos. 1 and 6), both of whom had (6e as Fig.3 Plasma concentrations of phenobarbital in ease No.17; loading dose 10 mg/kg, maintenance dose 5.3 mg/kg/12 hrs; accumulation of the drug during the following six days (5.2 mg/dl), discontinuing therapy for two days followed by reduction of the maintenance to 2.8 mg/kg/12 hrs resulted in plasma levels of 1.8 and 2.2 mg/dl nine and 16 days later; clinical seizures one and two days after the beginning of the anticonvulsive therapy; EEG was recorded two days before the last plasma level Table I EEG Outcome Background Seizure Activity Activity fracture from birth trauma (No. 24). In the two term infants, mild suppression was noted in the presence of phenobarbital levels of3.3 and 2.8 mg/dl, while in the premature infants the levels ranged from 1.7 to 3.0 mg/d!. Six ofthe infants survived and had developmental delay, motor abnormalities, and questionable visual deficits when evaluated at 5 to 12 months post conception.
Normal EEGs were noted in nine infants, six term and three premature. Five of the six term infants sufTered perinatal asphyxia (Nos. 15, 16, 18, 19 and 22) , while the sixth had hepatitis (No. 26). Electrical seizure discharges were present in four (Figs. 10 and 11 ). In this group the phenobarbital levels ranged from 1.3 to 5.0 mg/dl, with three being less than 2 mg/dl. The three prematures (Nos. 21, 23 and 25) had cere-
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bral and non-cerebral clinical diseases. Only one of the three had electrical seizure discharges. The phenobarbital levels were 1.4,2.1 and 2.2 mg/dl, respectively.
Five infants in this series (Nos. 9, 12, 16,18 and23) had EEGs prior to the first dose of phenobarbital (Table 111 ). In infant No. 18, mild background suppression improved to nor.. mal in spite of a high barbiturate level, 5.0 mg/dl. In infant No. 9, the viral encephalitis rather than the barbiturates changed the EEG activity from excessive slowing and numer.. ous central sharp waves to moderate suppression with multi- Fig.6 Case No. 2: Perinatal asphyxia, GA 41 weeks, 5 days old; burst-suppression pattern, beginning ongoing electrographic seizure over the right central area independent from the burst.. suppression pattern, duration 10 seconds, seizure was followed by eight seconds of almost inactive tracing; no clinical signs focal spike activity (Figs. 12 and 13) . In infants No. 12 and 16, no change in background activity occurred, even though barbiturates improved the seizure discharges. In infant No. 23, the EEG improved from a mild suppression with unifocal seizure discharge to normal.
In order to determine whether phenobarbital was a significant factor in changing the EEG background activity, the data were analyzed statistically using the method ofanalysis ofvariance. Comparisons were made between the range of pheno- arbital levels and three groups of EEGs: those with inactive, burst-suppression and moderate suppression (Group I); those with mild suppression (Group 11); and those with normal background activity (Group 111). The phenobarbital levels ranged from 1.6 to 5.9 mg/dl in Group I; from 1.7 to 3.3 mg/dl in Group 11; and from 1.3 to 5.0 mg/dl in Group III (Tables 1and 11) . No statistically significant differences existed between the three groups (p < 0.25).
Discussion
The influence of anticonvulsant therapy on the neonatal EEG has been reported by Couto-Sales et al (1979) . In their study, phenobarbital and diazepam plasma levels were determined one hour after the EEG was recorded. All phenobarbital levels were below 2.7 mg/dl. In the present study, there was no well-defined interval between determination of the Table 111 Cases with EEG prior to phenobarbital medication. Abbreviations: see Table I Backround Activity Seizure Activity c;;- , and little or no change in the plasma concentration would be expected during the 24 hours following administration of the drug. Secondly, in no case was an extra dose added to the maintenance therapy between EEG recording and measurement of the level. Thus, in most cases a "steady state" presumably had been reached, and the measured levels probably reflect the phenobarbital plasma concentrations at the time ofthe EEG recording.
To avoid the destructive effects of prolonged seizure activity (Epstein and 0 ·Connor 1966), early and aggressive therapy of neonatal seizures is recommended (Pippenger and Rosen 1975) . Even in the absence of a clear dose response relationship between phenobarbital and the disappearance of seizures, it is suggested that a high concentration of drug should be attained as soon as possible to determine whether other forms of treatment should be added. Therefore, it has been recommended that phenobarbital should be started with a loading dose in order to obtain a prompt therapeutic level. Small repeated doses do not produce the desirable plasma levels and result only in a gradual approach to "steady state" (Jalfing 1975, Wal/ing et al 1974). Since it was necessary to administer additional phenobarbital in 13 of 23 cases who received a loading dose of 10-14 mglkg, a higher dose, the recommendation of Painter et al (1978) using 15-20 mglkg is suggested.
Maintenance therapy above 5 mglkglday may result in dangerous accumulation of phenobarbital (Fig.3) . In some cases, even daily doses of 5 mglkg may lead to accumulation of drug (Fig. 4) . Therefore, it is necessary to monitor the plasma concentrations at frequent intervals (Pippenger and Rosen 1975) , particularly during the first days oftreatment.
Many studies beginning with those of the early electroencephalographers, Berger (1934) and Gibbs et al (1937) , describe the different effects of barbiturates on the EEG in man. Most studies involving adult patients under anesthesia or severe intoxication report that suppression due to barbiturates increases as the plasma concentration rises (Clark and Rosner 1973) . When consumed in massive doses, barbiturates are known to produce coma and prolong the isoelectric pattern of the EEG (Bird and Blum 1968, Mantz et al 1971) . E'nxel (1975) reported a case ofa neonate with a plasma barbiturate level of 11.7 mgldl who had an EEG which was nearly isoelectric until the phenobarbital level fell to 6.8 mg/dl. He concluded that the temporary flattening was secondary to thc high plasma concentration ofbarbiturate.
The burst-suppression pattern was first observed under deep barbiturate narcosis (Swank 1949) . Other forms of suppression which manifest during barbiturate anesthesia can be determined by EEG (Clark and Rosner 1973) . Even though in most reports of EEG suppression plasma barbiturate levels are not stated, many electroencephalographers confronted with a suppression pattern on a neonatal EEG relate the fi nding to medication, even when the plasma levels are in a therapeutic range. The relationship between the EEG and the plasma barbiturate level obviously is important to the question of the criteria for brain death.
There is titde published information about therapeutic levels ofphenobarbital in neonates with seizures. Jalling (1975) found an approximate range of 1.2 to 3.0 mgldl.
Couto-Sales et al (1979) describe the EEG during the first 24 hours of anticonvulsant therapy in 19 neonates. Tracings with burst-suppression pattern (paroxysmal tracing) were not noted, but two inactive tracings were seen. No information concerning outcome was reported. On the basis of clinical data, they concluded that the changes in the EEG were rclatcd to the severity of the brain pathology rather than the medication. Gabriel and Albani (1977) administered phenobarbital to seven healthy preterm infants and reported that at levels of ECG~----1IL---I'----+----l'----i'-....-t--f----J.-...-A-------1-- 1.9 to 3.5 mg/dl there was a reduetion ofthe amount of active sleep but no abnormal patterns were eneountered. In this study, the persistence of seizure aetivity on the EEG plus the alteration ofthe background aetivity related more to the severity of the underlying brain pathology than to the phenobarbital concentration in the plasma.
The toxie range for phenobarbital in aduIts is above 4.0 mg/dl, but in neonates this range has not been determined. Infants with levels above 4.0 to 6.0 mg/dl may be elinieally alert (Pippenger and Rosen 1975) . Two neonates in th~pre-sent study had levels in this range. Their EEG findings did not relate to the medieation. One infant had an EEG with normal
. , . -", ..." "~"w.~~Oq"""""",,T background activity; the other had an inactive tracing which persisted even after the phenobarbital level had dropped considerably. The evaluation of the EEG background activity of premature babies is more difficult than that of term infants. InsuffiStaudt et al cient data is available to define clear criteria for distinguishing the normal EEG from one with suppression of the background activity, especially in the very early gestational ages. It is very difficult to distinguish different stages of suppression because of the general irregularity and intermittent patterns which are normal for the infant born prematurely.
Before the advent of CT scans and echoencephalography, the interpretation of the EEG as normal was empirical and arbitrary. Now that intracranial hemorrhage in the very immature has been diagnosed more frequently (Papi/e et al 1978, Bejar et al 1980) , the criteria for defining anormal EEG in these infants may be better defined.
In term infants, inactive and burst-suppression patterns have been shown to occur in severely diseased neonates who did not survive or developed a severe encephalopathy (Monod and Ducas 1968 , Dreyjus-Brisac etal 1969 , EnKel 1975 , Tharp et al 1977 , Watanabe 1978 . The poor prognosis of these patterns is confirmed by the demise of five neonates in the present study who showed these abnormalities in their EEG.
This study shows a clear relationship between background EEG activity and clinical outcome. The EEG findings appear unrelated to the phenobarbital plasma concentrations. Thos, the suppression of the EEG background activity seen in neonates with plasma levels of phenobarbital within a range of 1.3 to 5.9 mg/dl are secondary to brain pathology rather than medication. This should aid the electroencephalographer in giving a more accurate prognostic interpretation.
Zusammenfassung
Es ist bekannt, daß hohe Phenobarbitalplasmakonzentrationen deutliche Änderungen der EEG-Grundaktivität her- 
